117 related articles for article (PubMed ID: 25394444)
1. Double primary carcinoma in a renal allograft recipient.
Satish R; Rout P; Alexander B
Saudi J Kidney Dis Transpl; 2014 Nov; 25(6):1251-4. PubMed ID: 25394444
[TBL] [Abstract][Full Text] [Related]
2. A randomized trial of cyclosporine and prednisolone versus cyclosporine, azathioprine, and prednisolone in primary cadaveric renal transplantation.
Lindholm A; Albrechtsen D; Tufveson G; Karlberg I; Persson NH; Groth CG
Transplantation; 1992 Oct; 54(4):624-31. PubMed ID: 1412754
[TBL] [Abstract][Full Text] [Related]
3. Steroid and azathioprine versus steroid, cyclosporine, and azathioprine therapies in primary haplo-identical living donor kidney transplantation: twenty-year experience.
Gheith OA; Bakr MA; Fouda MA; Shokeir AA; Bayoumy A; Sobh M; Ghoneim M
Iran J Kidney Dis; 2008 Jan; 2(1):34-9. PubMed ID: 19367007
[TBL] [Abstract][Full Text] [Related]
4. Modifying cyclosporine associated renal allograft dysfunction.
Mohapatra N; Vanikar AV; Patel RD; Trivedi HL
Saudi J Kidney Dis Transpl; 2009 Sep; 20(5):770-4. PubMed ID: 19736471
[TBL] [Abstract][Full Text] [Related]
5. Retrospective study of cyclosporine-prednisolone versus cyclosporine-azathioprine-prednisolone immunosuppression in living donor kidney transplantation.
Reissi D; Bardideh A; Samadzadeh B; Razi A
Transplant Proc; 1995 Oct; 27(5):2685-6. PubMed ID: 7482875
[No Abstract] [Full Text] [Related]
6. Conversion of cyclosporine to azathroprine in renal transplant recipients.
Bassiri A; Amiranssari B; Gol S
Transplant Proc; 1995 Oct; 27(5):2691. PubMed ID: 7482877
[No Abstract] [Full Text] [Related]
7. Successful conversion from cyclosporine to azathioprine in elective renal transplant recipients.
Chuang FR; Hsieh H; Hsu KT; Chien YS; Chung HM
Transplant Proc; 1998 Nov; 30(7):3094-6. PubMed ID: 9838365
[No Abstract] [Full Text] [Related]
8. Allochronic overlapping malignancies after renal transplantation in a patient with p53 gene mutation: report of a case.
Kitayama T; Marubayashi S; Hayamizu K; Tashiro H; Ohdan H; Ikeda S; Okimoto T; Okajima M; Kataoka T; Sugino K; Asahara T; Fukuda Y; Dohi K
Surg Today; 2004; 34(5):473-6. PubMed ID: 15108094
[TBL] [Abstract][Full Text] [Related]
9. Trial of steroid withdrawal in renal transplant recipients with long-term--surviving allograft.
Mizuno Y; Kikuchi H; Fujimori K; Doi H; Orii T; Ohkohchi N; Satomi S
Transplant Proc; 2000 Nov; 32(7):1677-8. PubMed ID: 11119888
[No Abstract] [Full Text] [Related]
10. Optimal combination of immunosuppressive agents for renal transplantation: first report of a multicentre, randomised trial comparing cyclosporine+prednisolone with cyclosporine+azathioprine and with triple therapy in cadaver renal transplantation. The Australian Collaborative Trials Committee.
Hardie IR; Tiller DJ; Mahony JF; Miach PJ; Thomson NM; Thatcher GN; Rigby RJ; Menzies BL
Transplant Proc; 1993 Feb; 25(1 Pt 1):583-4. PubMed ID: 8438424
[No Abstract] [Full Text] [Related]
11. High incidence of posttransplant diabetes mellitus in renal transplant recipients on triple-drug immunosuppression.
Sakhuja V; Sharma UK; Jha V; Minz M; Chugh KS
Transplant Proc; 1995 Oct; 27(5):2728-30. PubMed ID: 7482892
[No Abstract] [Full Text] [Related]
12. Neoquadruple induction with antithymocyte globulin/azathioprine/cyclosporine/prednisolone in simultaneous pancreas and kidney transplant recipients: 8.5-year results.
Schulz T; Kapischke M; Busing M
Transplant Proc; 2005 May; 37(4):1815-7. PubMed ID: 15919475
[TBL] [Abstract][Full Text] [Related]
13. Esophageal candidiasis after renal transplantation: comparative study in patients on different immunosuppressive protocols.
Gupta KL; Ghosh AK; Kochhar R; Jha V; Chakrabarti A; Sakhuja V
Am J Gastroenterol; 1994 Jul; 89(7):1062-5. PubMed ID: 8017366
[TBL] [Abstract][Full Text] [Related]
14. Double endocrine neoplasia in a renal transplant recipient: case report and review of the literature.
Lo Monte AI; Palumbo VD; Damiano G; Maione C; Florena AM; Gioviale MC; Spinelli G; Bellavia M; Cacciabaudo F; Buscemi G
Transplant Proc; 2011 May; 43(4):1201-5. PubMed ID: 21620089
[TBL] [Abstract][Full Text] [Related]
15. Microemulsified cyclosporine-based immunosuppression for the prevention of acute renal allograft rejection in unrelated dogs: preliminary experimental study.
Bernsteen L; Gregory CR; Kyles AE; Griffey SM; Patz J
Vet Surg; 2003; 32(3):213-9. PubMed ID: 12784197
[TBL] [Abstract][Full Text] [Related]
16. Conversion from cyclosporine to azathioprine at three months reduces the incidence of chronic allograft nephropathy.
Bakker RC; Hollander AA; Mallat MJ; Bruijn JA; Paul LC; de Fijter JW
Kidney Int; 2003 Sep; 64(3):1027-34. PubMed ID: 12911553
[TBL] [Abstract][Full Text] [Related]
17. Does low-dose allopurinol, with azathioprine, cyclosporin and prednisolone, improve renal transplant immunosuppression?
Chocair PR; Duley JA; Cameron JS; Arap S; Ianhez L; Sabbaga E; Simmonds HA
Adv Exp Med Biol; 1994; 370():205-8. PubMed ID: 7660891
[No Abstract] [Full Text] [Related]
18. The transmission of donor-derived malignant melanoma to a renal allograft recipient.
Milton CA; Barbara J; Cooper J; Rao M; Russell C; Russ G
Clin Transplant; 2006; 20(5):547-50. PubMed ID: 16968479
[TBL] [Abstract][Full Text] [Related]
19. Results of clinical renal transplantation in 15 dogs using triple drug immunosuppressive therapy.
Gregory CR; Kyles AE; Bernsteen L; Mehl M
Vet Surg; 2006 Feb; 35(2):105-12. PubMed ID: 16472290
[TBL] [Abstract][Full Text] [Related]
20. Excellent outcome with a calcium channel blocker-supplemented immunosuppressive regimen in cadaveric renal transplantation. A potential strategy to avoid antibody induction protocols.
Suthanthiran M; Haschemeyer RH; Riggio RR; Adubor C; Friedman GS; Cheigh JS; Wang JC; Fotino M; Stubenbord WT; Saal SD
Transplantation; 1993 May; 55(5):1008-13. PubMed ID: 8497873
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
